Friday, July 04, 2025 | 03:20 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap (    %)
                             
Nifty Smallcap (    %)
                             
Nifty Bank (    %)
                             
Nifty IT (    %)
                             
Home / Markets / Ajanta Pharma Ltd / Announcements / BSE

Ajanta Pharma Ltd

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

12:15 PM, 30th Jun 2025

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 30 2025 for Ravi Agrawal trustee Ravi Agrawal Trust

More Ajanta Pharma Ltd Announcements

    View more
    Business Standard
    Copyrights © 2025 Business Standard Private Ltd. All rights reserved
    LinkedIN Icon